BSTZ
Overvalued by 97.9% based on the discounted cash flow analysis.
Market cap | $1.46 Billion |
---|---|
Enterprise Value | $1.46 Billion |
Dividend Yield | $1.24 (8.19418181818182%) |
Earnings per Share | $3.68 |
Beta | 1.4 |
Outstanding Shares | 76,070,675 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 6.9 |
---|---|
PEG | 6.28 |
Price to Sales | - |
Price to Book Ratio | 1.91 |
Enterprise Value to Revenue | 99.82 |
Enterprise Value to EBIT | 9.03 |
Enterprise Value to Net Income | 3 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data
BlackRock Science and Technology Trust II, is a limited-term closed-end equity fund. BSTZ commenced operations in June 2019 with the investment objectives of providing total return and income through a combination of current income, curr...